NCT05867641 · RECRUITING

VR&R: Providing Caregiver Respite by Managing BPSDs and Improving QoL in People with Dementia Using Immersive VR-Therapy

This trial is testing whether immersive virtual reality therapy used at home can help people with dementia feel calmer and better, while giving their family caregivers a genuine mental break. It compares two VR formats: solo viewing and shared viewing with a researcher. Phase NA means this is not a standard drug trial — it is a behavioral study evaluating how well the approach works in real home settings. Details on effectiveness are still being gathered.

Eligibility criteria

Inclusion Criteria: People with dementia
* Individuals who are 65 years of age or older
* Individuals living at home with a family caregiver
* Individuals diagnosed with dementia
Exclusion Criteria:
* Individuals with open wounds on face (sutured lacerations exempted)
* Individuals with a history of seizures or epilepsy
* Individuals with a pacemaker
* Individuals with head trauma or stroke leading to their current admission
* Individuals with cervical conditions or injuries that would make it unsafe for them to use the VR headset
* Individuals who identify as being legally blind
* Individuals with alcohol related dementia/ Korsakoff syndrome.
* Individuals who have a Public Guardian and Trustee (PGT) as Substitute Decision Maker (SDM)
* Individuals who cannot speak and understand English
Caregiver inclusion criteria:
* Individuals who identify as a primary caregiver for the PwD
* Individuals who have access to the internet through a device (computer, tablet, or mobile phone) that can be used during the study
Caregiver exclusion criteria:
* Individuals who cannot speak and understand English
* Individuals who are cognitively unable to provide informed consent for themselves
* Identify as legally blind

The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.

Eligibility criteria as of 2025-03-28

View full record on ClinicalTrials.gov

All APOE4 clinical trials